Answers are grounded in this paper and cite their sources.
Gestational diabetes mellitus (GDM) is a prevalent pregnancy-associated metabolic disorder characterized by impaired glucose homeostasis and placental dysfunction. Cyclin-dependent kinase 1 (CDK1) has emerged as a regulator of ferroptosis, but its role in GDM remains unclear. Placental tissues from women with GDM and normoglycemic pregnancies were analyzed to assess CDK1 expression and ferroptosis-related alterations. High glucose-treated HTR-8/SVneo and TEV-1 trophoblast cells were used to investigate the effects of CDK1 on ferroptosis and glucose uptake. Protein interaction, cycloheximide chase, and ubiquitination assays were performed to explore the underlying mechanism. Rescue experiments used ACSL4 overexpression. A streptozotocin (STZ)-induced GDM mouse model was established to validate the in vivo effects of CDK1. CDK1 expression was significantly reduced in GDM placentas and was negatively associated with hyperglycemia, insulin resistance, and iron overload. GDM placentas exhibited increased lipid peroxidation and impaired antioxidant capacity. In trophoblast cells, high glucose suppressed CDK1 expression and enhanced sensitivity to ferroptotic injury. CDK1 overexpression attenuated lipid peroxidation, iron accumulation, and ferroptosis-associated changes while enhancing glucose uptake. Mechanistically, CDK1 interacted with ACSL4 and regulated its protein stability through the ubiquitin-proteasome pathway. ACSL4 overexpression largely abolished the protective effects of CDK1. In streptozotocin-induced GDM mice, Cdk1 overexpression improved glucose tolerance, attenuated ferroptosis, reduced iron deposition and lipid peroxidation, and improved fetal growth parameters. Importantly, insulin-mediated glycemic normalization in STZ-treated mice reversed placental CDK1 downregulation and ferroptosis-related changes, whereas insulin alone had no significant effect, supporting an important contribution of hyperglycemia to these alterations, although direct STZ effects and glucose-independent effects of insulin cannot be completely excluded. CDK1 acts as a protective regulator of trophoblast function in GDM by suppressing ACSL4-dependent ferroptosis and improving glucose metabolic homeostasis. These findings identify the CDK1/ACSL4 axis as an unrecognized mechanism involved in GDM pathogenesis.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: